Christopher D. Herzog

2.7k total citations
28 papers, 1.9k citations indexed

About

Christopher D. Herzog is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Christopher D. Herzog has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 13 papers in Cognitive Neuroscience. Recurrent topics in Christopher D. Herzog's work include Nerve injury and regeneration (18 papers), Autism Spectrum Disorder Research (8 papers) and Virus-based gene therapy research (6 papers). Christopher D. Herzog is often cited by papers focused on Nerve injury and regeneration (18 papers), Autism Spectrum Disorder Research (8 papers) and Virus-based gene therapy research (6 papers). Christopher D. Herzog collaborates with scholars based in United States, Germany and Canada. Christopher D. Herzog's co-authors include Raymond T. Bartus, Mehdi Gasmi, Jeffrey H. Kordower, Tim Otto, Jeffrey H. Kordower, Lamar Brown, Biplob Dass, João Siffert, Roy A.E. Bakay and Alistair Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Cancer Research.

In The Last Decade

Christopher D. Herzog

28 papers receiving 1.9k citations

Peers

Countries citing papers authored by Christopher D. Herzog

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Herzog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Herzog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Herzog more than expected).

Fields of papers citing papers by Christopher D. Herzog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Herzog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Herzog. The network helps show where Christopher D. Herzog may publish in the future.

Co-authorship network of co-authors of Christopher D. Herzog

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Herzog. A scholar is included among the top collaborators of Christopher D. Herzog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Herzog. Christopher D. Herzog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal 2020 ·Molecular Therapy — Methods & Clinical Development ·Ilana Moscatelli, Elena Almarza, Axel Schambach, David Ricks, Ansgar Schulz, Christopher D. Herzog, Kim Henriksen, Maria Askmyr, Jonathan D. Schwartz, Johan Richter	6
2	Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies 2015 ·Neurobiology of Disease ·Raymond T. Bartus, Jeffrey H. Kordower, Eugene M. Johnson, Lamar Brown, (unknown), Yaping Chu, Tiffany Baumann, Anthony E. Lang, C. Warren Olanow, Christopher D. Herzog	63
3	Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120) 2013 ·Neurobiology of Disease ·Christopher D. Herzog, Lamar Brown, (unknown), Alistair Wilson, Malú G. Tansey, Fred H. Gage, Eugene M. Johnson, Raymond T. Bartus	33
4	Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease 2012 ·Neurobiology of Aging ·Raymond T. Bartus, Tiffany Baumann, Lamar Brown, (unknown), Jeffrey M. Ostrove, Christopher D. Herzog	58
5	Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases 2011 ·Drug Delivery and Translational Research ·Christopher D. Herzog, Kathie M. Bishop, Lamar Brown, Alistair Wilson, Jeffrey H. Kordower, Raymond T. Bartus	25
6	Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains 2010 ·Movement Disorders ·Raymond T. Bartus, Christopher D. Herzog, Yaping Chu, Alistair Wilson, Lamar Brown, João Siffert, Eugene M. Johnson, C. Warren Olanow, Elliott J. Mufson, Jeffrey H. Kordower	133
7	EXPRESSION, BIOACTIVITY, AND SAFETY 1 YEAR AFTER ADENO-ASSOCIATED VIRAL VECTOR TYPE 2–MEDIATED DELIVERY OF NEURTURIN TO THE MONKEY NIGROSTRIATAL SYSTEM SUPPORT CERE-120 FOR PARKINSON'S DISEASE 2009 ·Neurosurgery ·Christopher D. Herzog, Lamar Brown, Dawn Gammon, (unknown), Richard Y. Lin, Alistair Wilson, (unknown), Marie A. Printz, Mehdi Gasmi, Kathie M. Bishop, Jeffrey H. Kordower, Raymond T. Bartus	62
8	FOXO3a elicits a stress-specific cellular response involving the activation of distinct transcription programs 2008 ·Cancer Research ·Oliver R. Mikse, (unknown), Willard M. Freeman, Christopher D. Herzog	1
9	Striatal delivery of CERE‐120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys 2007 ·Movement Disorders ·Christopher D. Herzog, Biplob Dass, James E. Holden, (unknown), Mehdi Gasmi, Mark H. Tuszynski, Raymond T. Bartus, Jeffrey H. Kordower	114
10	Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease 2007 ·Neurobiology of Disease ·Shilpa Ramaswamy, Jodi L. McBride, Christopher D. Herzog, Eugene P. Brandon, Mehdi Gasmi, Raymond T. Bartus, Jeffrey H. Kordower	29
11	AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease 2007 ·Neurobiology of Disease ·Mehdi Gasmi, Eugene P. Brandon, Christopher D. Herzog, Alistair Wilson, Kathie M. Bishop, (unknown), Justine J. Cunningham, Marie A. Printz, Jeffrey H. Kordower, Raymond T. Bartus	117
12	Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys 2006 ·Annals of Neurology ·Jeffrey H. Kordower, Christopher D. Herzog, Biplob Dass, Roy A.E. Bakay, (unknown), Mehdi Gasmi, Raymond T. Bartus	195
13	Striatal Delivery of Neurturin by CERE-120, an AAV2 Vector for the Treatment of Dopaminergic Neuron Degeneration in Parkinson's Disease 2006 ·Molecular Therapy ·Mehdi Gasmi, Christopher D. Herzog, Eugene P. Brandon, Justine J. Cunningham, G. Ramirez, (unknown), Raymond T. Bartus	125
14	Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington’s disease 2006 ·Proceedings of the National Academy of Sciences ·Jodi L. McBride, Shilpa Ramaswamy, Mehdi Gasmi, Raymond T. Bartus, Christopher D. Herzog, Eugene P. Brandon, Lili Zhou, Mark R. Pitzer, Elizabeth Berry‐Kravis, Jeffrey H. Kordower	79
15	Behavioral and neuropsychological foundations of olfactory fear conditioning 2000 ·Behavioural Brain Research ·Tim Otto, Graham Cousens, Christopher D. Herzog	88
16	Effects of Intraseptal Zolpidem and Chlordiazepoxide on Spatial Working Memory and High-Affinity Choline Uptake in the Hippocampus 2000 ·Neurobiology of Learning and Memory ·Christopher D. Herzog, Chetan C. Gandhi, (unknown), Thomas J. Walsh	18
17	Regeneration of olfactory receptor neurons following chemical lesion: time course and enhancement with growth factor administration 1999 ·Brain Research ·Christopher D. Herzog, Tim Otto	38
18	Contributions of anterior perirhinal cortex to olfactory and contextual fear conditioning 1998 ·Neuroreport ·Christopher D. Herzog, Tim Otto	36
19	Intraseptal Flumazenil Enhances, while Diazepam Binding Inhibitor Impairs, Performance in a Working Memory Task 1996 ·Neurobiology of Learning and Memory ·Christopher D. Herzog, Robert W. Stackman, Thomas J. Walsh	27
20	Partial trisomy 8q. Two case reports with maternal translocation and inverted insertion: phenotype analyses and reflections on the risk 1992 ·Clinical Genetics ·S. Stengel‐Rutkowski, Konrad Lohse, Christopher D. Herzog, Can Apacik, J. Couturier, (unknown), B. H. Belohradsky	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact